To investigate the role of FTO‐mediated regulation of IGFBP3 in lung cancer progression, we first compared FTO and IGFBP3 transcript levels in paired tumour and adjacent normal tissues from 36 LUAD patients. The gene discussed is FTO; the disease is lung carcinoma.